In vitro evaluation of erythromycin in chloroquine resistant Brazilian P. falciparum freshly isolates: Modulating effect and antimalarial activity evidence

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 41, Issue 4, 1999, Pages 249-253

  Menezes, Carla M S ^a   Kirchgatter, Karln ^b   Di Santi, Sílvia M F ^b   Savalli, Carine ^a   Monteiro, Fabiola G ^a   Paula, Gilberto A ^a   Ferreira, Elizabeth I ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Divisao de Programas Especiais   (Brazil)

Author keywords

Antimalarial activity; Chloroquine P. falciparum resistance; Erythromycin; Modulating effect

Indexed keywords

CHLOROQUINE; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BRAZIL; CASE REPORT; DRUG EFFECT; DRUG SENSITIVITY; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM;

EID: 0032858941     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46651999000400009     Document Type: Article

References (36)

1. ANDERSEN, S.L.; OLOO, A.J.; GORDON, D.M. et al. - Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in Western Kenya. Clin. infect. Dis., 26: 146-150, 1998.
2. BASCO, L.K. & LE BRAS, J. - In vitro activities of chloroquine in combination with chlorpromazine and prochlorperazine against isolates of Plasmodium falciparum. Antimicrob. Agents Chemother., 36: 209-213, 1992.
3. BENET, L.Z.; OIE, S. & SCHWARTZ, J.B. - Design and optimization of dosage regimens: pharmacokinetic data. In: HARDMAN, J.G.; LIMBIRD, L.E.; MOLINOFF, P.B.; RUDDON, R.W. & GILMAN, A.G. - Goodman & Gilman's: the pharmacological basis of therapeutics. 9. ed. New York, Pergamon Press, 1996. p.1707-1792.
4. BOER, R. & GEKELER, V. - Chemosensitizers in tumor therapy: new compounds promise better efficacy. Drugs Fut., 20: 499-509, 1995.
5. BRANDLING-BENNETT, A.D.; OLOO, A.J.: KHAN, B. & WATKINS, W.M. - Failure of erythromycin to improve chloroquine treatment of Plasmodium falciparum in Kenya. Trans. roy. Soc. trop. Med. Hyg., 82: 363-365, 1988.
6. BRAY, P.G. & WARD, S.A. - A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum. Pharmacol. Therap., 77: 1-28, 1998.
7. BRESLOW, N.E. & DAY, N M. - Statistical methods in cancer research. 1. The analysis of case control studies. Lyon, International Agency for Research on Cancer, 1980.
8. BRUCE-CHWATT, L.J., ed. - Chemotherapy of malaria. 2. ed. Geneva, World Health Organization. 1982. p. 211-223.
9. CLARKE, E.C. - Isolation and identification of drugs in pharmaceuticals, body fluids and post-mortem material. 2. ed. London, Pharmaceutical Press, 1986. p. 588-589.
10. COLLETI, D. - Modelling binary data. London, Chapman & Hall, 1991.
11. DRUGDEK(R) SYSTEM - Drug evaluation monographs. In: Micromedex CCIS-Computerized Chemical Information System (R), v. 73, 1992. [CDROM].
12. FOLEY, M.& TILLEY, L. - Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents Pharmacol. Therap., 79: 55-87, 1998.
13. FORD, J.M. & HATT, W.N. - Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev., 42: 155-199, 1990.
14. GLARY, T.G. & JENSEN, J.B. - Effects of antibiotics on Plasmodium falciparum in vitro. Amer. J. trop. Med. Hyg., 32: 221-225, 1983.
15. GERSHON, P.D. & HOWELLS, R.E. - Combination of the antibiotics erythromycin and tetramycine with three standard antimalarials against Plasmodium falciparum in vitro. Ann. trop. Med. Parasit., 78: 1-11, 1984.
16. HOFSLI, E. & NISSEN-MEYER, J. - Effect of erythromycin and tumour necrosis factor on the drug resistance of multidrug-resistant cells: reversal of drug resistance by erythromycin. Int. J. Cancer, 43: 520-525, 1989.
17. HOFSLI, E. & NISSEN-MEYER, J. - Reversal of multidrug resistance by lipophilic drugs. Cancer Res., 50: 3997-4002, 1990.
18. KHAN, B.; BRANDLING-BENNETT, A.D.; WATKINS, W.M. et al. - Plasmodium falciparum sensitivity to erythromycin and 4-aminoquinoline combinations in vitro. Ann. trop. Med. Parasit., 85: 215-222, 1991.
19. KREMSNER, P.G.; WINKLER, S.; BRANDTS, C.; GRANINGER, W. & BIENZLE, U. - Curing of chloroquine-resistant malaria with clindamycin. Amer. J. trop. Med. Hyg., 49: 650-654, 1593.
20. KUSCHNER, R.A.; HEPPNER, D.G.; ANDERSEN, S.L. et al. - Azithromycin prophylaxis against a choroquine-resistant strain of Plamodium falciparum. Lancet, 343: 1396-1397, 1994.
21. LE BRAS, J. & DELORON, P. - In view study of drug sensitivity of Plasmodium falciparum evaluation of a new semi-micro test. Amer. J. trop. Mod. Hyg., 32: 447-451, 1983.
22. MARTIN,S.K.; ODUOLA, A.M. & MILHOUS,W.K. - Reversal of chloroqine resistance in Plasmodium falciparum by verapamil, Science, 235: 899-901, 1987.
23. MENEZES, C.M.S. - Estudo da influência das proprledades fisico-quimicas na reversão da resistência do Plasmodium falciparum à cloroquina. São Paulo, 1997. (Tese de Doutoramento - Faculdade de Ciências Formacêuticas da Universidade de São Paulo).
24. PANG, L.W.; BOUDREAU, E.F.; CHILDS, G.E. et al. - Failure of large-dose erythromycin in combination with a standard dose of chloroquine or quinine in the treatment of human falciparum malaria. Bull. Wld. Hlth. Org., 63: 739-743, 1985.
25. PHILLIPS, R.E.; LOOAREESUWAN, S.; KARBWANG, J. et al. - Failure of chloroquine/ erythromycin chloroquine/tetracycline combinations in treatment of chloroquine-resistant falciparum malaria in Eastern Thailand. Lancet, 1: 300-302, 1984.
26. RADERER, M. & SCHEITHAUER, W. - Clinical trials of agents that reverse multidrug resistance. Cancer, 72: 3553-3563, 1993.
27. RIECKMANN, K.H.; SAX, L.J.; CAMPBELL, G.H. & MREMA, J.E. - Drug sensitivity of Plasmodium falciparum. An in vitro microtechnique. Lancet, i: 22-23, 1978.
28. ROBINSON, B.L. & WARHURST, D.C. - Antimalarial activity of erythromycin. Trans. roy. Soc. trop. Med. Hyg., 66: 525, 1972.
29. STRATH, M.; SCOTT-FINNIGAN, T.; GARDNER, M.; WILLIAMSON, D. & WILSON, I. - Antimalarial activity of rifampicin in vitro and in rodent models. Trans. roy. Soc. trop. Med. Hyg., 87: 211-216, 1993.
30. THE MALARIA FOUNDATION - Fact Pack. (1997). [on line 01/23/98]. Available from: www.malaria.org.
31. TRAGER, W. & . ENSEN, B.B. - Human malaria parisites in continuous culture. Science, 193: 673-675, 1976.
32. WARHURST, D.C.; ROBINSON, B.L. & PETERS, W. - The chemotherapy of rodent malaria. XX. V. The blood schizontocidal action of crythromycin upon Plasmodium berghei. Ann. trop. Med. Parasit., 70: 253-258, 1976.
33. WORLD HEALTH ORGANIZATION - Division of Control of Tropical Disease/Malaria Prevention and Control. [on line 5/26/99]. Available from: www.who.
34. WORLD HEALTH ORGANIZATION - WHO Model Prescribing Information. Drugs used in Parasitic Diseases, 2.ed. Geneva, World Health Organization, 1995, p. 24-54.
35. YE, Z. & VAN DYKE, K. - Interaction of artemisnin and tetracycline or erythromycin against Plasmodium falsiparum in vitro, Parasite, 1: 211-218, 1994.
36. YEO, A.E. & RIECKMANN, K.H.-The in vitro antimalarial activity of chloramphenicol against Plasmodium falciparum. Acta trop. (Basel), 56: 51-54, 1994.